From: Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study
Case
Week confirming clinical remissiona
Week confirming clinical recurrencea
Final observation without recurrencea
Corticosteroid free remissionb
1
6
-
52
46 weeks
4
36
30 weeks
5
28
24 weeks